63-year-old gentleman, oligometastatic prostate cancer. - Nuclear Care MD
June 19, 2023
iPSA level 35 ng/ml. Single-dose of Lu-177 PSMA (Pluvicto) therapy cause disappearance of primary prostate lesion as well as metastatic lymph nodes. Patient continue in remission for last one-year. Latest PSA level 0.1 ng/ml.
nukesadmin